Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 12, 2021
Reporting Period: The filing announces financial results for the three and six months ended June 30, 2021.
Key Financial Metrics
This Form 8-K serves as a notification of the release of financial results and does not contain specific numerical data within the text provided. The filing references a press release (Exhibit 99.1) for detailed figures.
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide clear values for these metrics. Investors must refer to the attached press release (Exhibit 99.1) for specific numbers.
Material Changes
The filing does not detail specific material changes or comparative analysis against prior periods within the body text. It solely indicates that results for the periods ended June 30, 2021, have been issued.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The text does not include specific guidance, outlook, or management commentary beyond the announcement of the results.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Unusual Items: None reported in the text of this Form 8-K.
Important Facts for Investor Verification
- Verify the specific financial figures (revenue, net loss, cash position) in the press release dated August 12, 2021, referenced as Exhibit 99.1.
- Note that the information in Item 2.02 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference unless expressly stated.
- Confirm the company's status as an emerging growth company (indicated as not checked in the form).